Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (841-850 of 13,993) with videos related to

Pageof 1,400
Sort By:
Leukemia|August 7, 2009
Sunitinib, an orally available receptor tyrosine kinase inhibitor, induces monocytic differentiation of acute myelogenous leukemia cells that is enhanced by 1,25-dihydroxyvitamin D(3)C Nishioka, T Ikezoe, J Yang, et al.
Leukemia|August 7, 2009
Low doses of 2-deoxy-glucose sensitize acute lymphoblastic leukemia cells to glucocorticoid-induced apoptosisK Eberhart, K Renner, I Ritter, et al.
Leukemia|September 1, 1991
Immunoglobulin and T-cell receptor gene rearrangements in acute non-lymphocytic leukemias. Analysis of 54 cases and a review of the literatureH J Adriaansen, P W Soeting, I L Wolvers-Tettero, et al.
Leukemia|September 1, 1991
Interferon gamma induces differentiation of cells from patients with myelodysplastic syndromes in vitro and in vivoY Yoshida
Leukemia|September 1, 1991
Models of childhood acute lymphoblastic leukaemiaM F Greaves
Leukemia|September 1, 1991
HPRT mutation frequency as an index of chemical or radiation damageB Bridges
Leukemia|September 1, 1991
Naturally occurring radiationD Sanderson
Leukemia|May 14, 2009
The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophagesA Carbonnelle-Puscian, C Copie-Bergman, M Baia, et al.
Leukemia|May 15, 2009
Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemiaK Giannopoulos, A Dmoszynska, M Kowal, et al.
Leukemia|May 15, 2009
Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 studyB-S Cho, S Lee, Y-J Kim, et al.
Pageof 1,400

Showing results (841-850 of 13,993) with videos related to

Sort By:
Pageof 1,400
Leukemia|August 7, 2009
Sunitinib, an orally available receptor tyrosine kinase inhibitor, induces monocytic differentiation of acute myelogenous leukemia cells that is enhanced by 1,25-dihydroxyvitamin D(3)C Nishioka, T Ikezoe, J Yang, et al.
Leukemia|August 7, 2009
Low doses of 2-deoxy-glucose sensitize acute lymphoblastic leukemia cells to glucocorticoid-induced apoptosisK Eberhart, K Renner, I Ritter, et al.
Leukemia|September 1, 1991
Immunoglobulin and T-cell receptor gene rearrangements in acute non-lymphocytic leukemias. Analysis of 54 cases and a review of the literatureH J Adriaansen, P W Soeting, I L Wolvers-Tettero, et al.
Leukemia|September 1, 1991
Interferon gamma induces differentiation of cells from patients with myelodysplastic syndromes in vitro and in vivoY Yoshida
Leukemia|September 1, 1991
Models of childhood acute lymphoblastic leukaemiaM F Greaves
Leukemia|September 1, 1991
HPRT mutation frequency as an index of chemical or radiation damageB Bridges
Leukemia|September 1, 1991
Naturally occurring radiationD Sanderson
Leukemia|May 14, 2009
The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophagesA Carbonnelle-Puscian, C Copie-Bergman, M Baia, et al.
Leukemia|May 15, 2009
Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemiaK Giannopoulos, A Dmoszynska, M Kowal, et al.
Leukemia|May 15, 2009
Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 studyB-S Cho, S Lee, Y-J Kim, et al.
Pageof 1,400